In our second study on reference intervals, we show that the use of alternative diagnostic methods, such as a fixed limit of 4.0mU/L for TSH, results in considerably misdiagnosis of thyroid dysfunction. The paper is open access and is published in the Journal of Clinical Endocrinology and Metabolism.

Our first study on reference intervals is out. We have published an overview of usable reference intervals for TSH and FT4 in pregnancy, and show which criteria are important when selecting the reference population. The paper is open access and is published in the Journal of Clinical Endocrinology and Metabolism.

Dr. Sofie Bliddal and the consortium team quantify the association of TPO and Tg antibody concentrations with gestational thyroid function and show that it Tg antibodies are not independently associated with gestational TSH or FT4 concentrations.

In a new study, the Arkansas team in close collaboration with the Rotterdam team assessed the association of gestational thyroid function with preeclampsia. The full report is published in Lancet Diabetes & Endocrinology.

Our second study investigating the association of thyroid function with birth weight is now accepted for Lancet Diabetes & Endocrinology.

In collaboration with Dr. Rima Dhillon-Smith (the University of Brimingham), we aim to extend the consortium to include randomized trials. We aim to provide data on harms and benefits of levothyroxine treatment during pregnancy.

Our first study investigating the association of thyroid function with preterm birth is now published in the Journal of the American Medical Association.

We are happy to announce the launch of our website in July 2019. We hope that the Consortium on Thyroid and Pregnancy can further disseminate its efforts and results to all patients, healthcare practitioners and researchers worldwide.